FDA restricts sale of Essure contraceptive device, requires that women be informed of risks

The Food and Drug Administration said Monday that it is restricting the sale and distribution of Essure, a controversial contraceptive device that some patient advocates want taken off the market. Only health-care providers and facilities that guarantee women have been told about the device's risks in advance will be allowed to implant it. Using what […]Related:With $2 million, Kaiser Permanente wants to help revive underfunded gun-violence researchThe CDC researcher who mysteriously vanished in February has been found deadAmid new talk of criminalizing abortion, research shows the dangers of making it illegal for women
Source: Washington Post: To Your Health - Category: Consumer Health News Source Type: news